Louise Wang Zhiying Humphrey

Array ( [id] => 7436129 [patent_doc_number] => 20040185057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Therapeutical vaccination' [patent_app_type] => new [patent_app_number] => 10/480534 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 31035 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185057.pdf [firstpage_image] =>[orig_patent_app_number] => 10480534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256203 [patent_doc_number] => 20040259827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Compositions and methods for the abrogation of cellular proliferation utilizing the human immunodeficiency virus Vpr protein' [patent_app_type] => new [patent_app_number] => 10/734024 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19848 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259827.pdf [firstpage_image] =>[orig_patent_app_number] => 10734024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 376931 [patent_doc_number] => 07312031 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-12-25 [patent_title] => 'Alpha-complementation viral fusion assay' [patent_app_type] => utility [patent_app_number] => 10/729069 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11267 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/312/07312031.pdf [firstpage_image] =>[orig_patent_app_number] => 10729069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7323470 [patent_doc_number] => 20040137436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Method for measuring drug resistance' [patent_app_type] => new [patent_app_number] => 10/258150 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17040 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137436.pdf [firstpage_image] =>[orig_patent_app_number] => 10258150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4572345 [patent_doc_number] => 07824851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => '2′-branched nucleosides and Flaviviridae mutation' [patent_app_type] => utility [patent_app_number] => 10/715729 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 44876 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/824/07824851.pdf [firstpage_image] =>[orig_patent_app_number] => 10715729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649716 [patent_doc_number] => 20060135451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Vaccine' [patent_app_type] => utility [patent_app_number] => 10/534774 [patent_app_country] => US [patent_app_date] => 2003-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13856 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135451.pdf [firstpage_image] =>[orig_patent_app_number] => 10534774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5069421 [patent_doc_number] => 20070190523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Method and compositions for identifying anti-hiv therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 10/554287 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 195041 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190523.pdf [firstpage_image] =>[orig_patent_app_number] => 10554287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 397489 [patent_doc_number] => 07294458 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-13 [patent_title] => 'Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients' [patent_app_type] => utility [patent_app_number] => 10/695846 [patent_app_country] => US [patent_app_date] => 2003-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 13675 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/294/07294458.pdf [firstpage_image] =>[orig_patent_app_number] => 10695846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034512 [patent_doc_number] => 20050033022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Fusion proteins comprising HIV-1 Tat and/or Nef proteins' [patent_app_type] => utility [patent_app_number] => 10/687060 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 6202 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20050033022.pdf [firstpage_image] =>[orig_patent_app_number] => 10687060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7295033 [patent_doc_number] => 20040213799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response' [patent_app_type] => new [patent_app_number] => 10/686943 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19774 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20040213799.pdf [firstpage_image] =>[orig_patent_app_number] => 10686943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7471567 [patent_doc_number] => 20040096972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Chimeric plasmid comprising a replicative retroviral genome, and uses' [patent_app_type] => new [patent_app_number] => 10/677558 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8150 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096972.pdf [firstpage_image] =>[orig_patent_app_number] => 10677558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117399 [patent_doc_number] => 20050070700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Equine arteritis virus vaccine' [patent_app_type] => utility [patent_app_number] => 10/675444 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 25914 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070700.pdf [firstpage_image] =>[orig_patent_app_number] => 10675444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7269798 [patent_doc_number] => 20040058316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Use of recombinant antigens to determine the immune status of an animal' [patent_app_type] => new [patent_app_number] => 10/670695 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19477 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058316.pdf [firstpage_image] =>[orig_patent_app_number] => 10670695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089632 [patent_doc_number] => 20050009745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'TSG101 as inhibitor of HIV production' [patent_app_type] => utility [patent_app_number] => 10/666997 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20808 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009745.pdf [firstpage_image] =>[orig_patent_app_number] => 10666997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7407688 [patent_doc_number] => 20040106136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Method for testing drug susceptibility of HIV' [patent_app_type] => new [patent_app_number] => 10/663360 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 30518 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106136.pdf [firstpage_image] =>[orig_patent_app_number] => 10663360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7150941 [patent_doc_number] => 20040171568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Antiviral oligonucleotides targeting HIV' [patent_app_type] => new [patent_app_number] => 10/661099 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 35304 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171568.pdf [firstpage_image] =>[orig_patent_app_number] => 10661099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 376817 [patent_doc_number] => 07311915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'Method of producing an HIV-1 immune response' [patent_app_type] => utility [patent_app_number] => 10/659324 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7285 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/311/07311915.pdf [firstpage_image] =>[orig_patent_app_number] => 10659324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7333168 [patent_doc_number] => 20040131594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Methods and reagents for vaccination which generate a CD8 T cell immune response' [patent_app_type] => new [patent_app_number] => 10/653624 [patent_app_country] => US [patent_app_date] => 2003-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19718 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20040131594.pdf [firstpage_image] =>[orig_patent_app_number] => 10653624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7389070 [patent_doc_number] => 20040082934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Method of controlling pharmacokinetics of immunomodulatory compounds' [patent_app_type] => new [patent_app_number] => 10/650039 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8478 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082934.pdf [firstpage_image] =>[orig_patent_app_number] => 10650039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7164857 [patent_doc_number] => 20040076640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Vaccine compositions against infectious pathologies for mammals' [patent_app_type] => new [patent_app_number] => 10/642763 [patent_app_country] => US [patent_app_date] => 2003-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4835 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20040076640.pdf [firstpage_image] =>[orig_patent_app_number] => 10642763 [rel_patent_id] =>[rel_patent_doc_number] =>)